Item 7.01 Regulation FD Disclosure.



Members of Humana Inc.'s (the "Company") senior management team are scheduled to
meet with investors and analysts at industry conferences and various other
meetings between June 1, 2022 and June 30, 2022. During these conferences and
meetings, the Company intends to reaffirm its guidance of approximately $22.98
in diluted earnings per common share ("EPS") or approximately $24.50 in adjusted
earnings per common share ("Adjusted EPS"), in each case for the year ending
December 31, 2022 ("FY 2022"). Humana's GAAP and Adjusted EPS guidance
contemplates an explicit COVID-19 related headwind of $1.00 per diluted common
share as well as the estimated dilutive impact related to the pending
divestiture of the company's 60 percent ownership of Kindred at Home's Hospice
and Personal Care divisions. This guidance is consistent with the guidance
issued in Humana's press release dated April 27, 2022. The date and time of
presentations to investors are available via the Investor Relations calendar of
events on the Company's website at www.humana.com.

The Company has included Adjusted EPS in this current report, a financial
measure that is not in accordance with Generally Accepted Accounting Principles
("GAAP"). Management believes that this measure, when presented in conjunction
with the comparable measure of GAAP EPS, is useful to both management and its
investors in analyzing the Company's ongoing business and operating performance.
Consequently, management uses Adjusted EPS as an indicator of the Company's
business performance, as well as for operational planning and decision making
purposes. Adjusted EPS should be considered in addition to, but not as a
substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to
Adjusted EPS follows:

               Diluted earnings per common share                             FY 2022 Guidance
GAAP                                                                                  approximately $22.98
Amortization of identifiable intangibles                                                              0.44
Put/call valuation adjustments associated with Company's                                     (0.12)
non-consolidating minority interest investments
Transaction and integration costs associated with the Kindred at                              0.54
Home acquisition
Change in fair market value of publicly-traded equity securities                              0.66
Adjusted (non-GAAP) - FY 2022 projected

approximately $24.50

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses